Promoter Dhirendra Dubey Acquires Shares in 3B BlackBio Dx Limited
Dhirendra Dubey has acquired a tranche of equity shares in 3B BlackBio Dx Limited (formerly Kilpest India Limited), increasing his holding in the company. The acquisition took place on June 24, 2026.The transaction involved Mr. Dhirendra Dubey, who belongs to the Promoter group, acquiring 1,000 equity shares of 3B BlackBio Dx Limited through the open market.
This acquisition updates the promoter's holding in 3B BlackBio Dx Limited. Before the purchase, the acquirer held 7,24,098 shares, representing 8.44 percent of the voting capital. Following the transaction, his shareholding increased to 7,25,098 shares, corresponding to 8.45 percent of the voting capital.
The key financial and shareholding details related to the acquisition are summarized below:
| Metric | Before Acquisition | After Acquisition |
|---|---|---|
| Shares Carrying Voting Rights | 7,24,098 | 7,25,098 |
| Percentage of Voting Capital | 8.44% | 8.45% |
| Equity Share Capital (Total) | Rs 8,58,26,700 | Rs 8,58,26,700 |
The company's equity share capital before the acquisition was reported as Rs 8,58,26,700, consisting of 8,58,267 shares of Rs 10/- each. After the acquisition, the company's equity share capital remains at Rs 8,58,26,700, based on 85,92,670 equity shares of Rs 10/- each. The total diluted share/voting capital after this transaction is reported as Rs 8,58,26,700, based on 85,82,670 equity shares of Rs 10/- each.
3BBLACKBIO Stock Price Movement
As of 12:49 PM, shares of 3B Blackbio Dx Limited are shedding value by 1.15% in live trading, currently priced at ₹1157 after falling more than the open price of ₹1173.9.The stock has seen brisk activity today, with a total traded volume of 4,484 shares as the equity navigates its intraday range.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.